OpenAI launches GPT-Rosalind for life sciences and drug discovery, with Amgen, Moderna, and Allen Institute on early access - Openai

Rickler Feed (@rickler_feed), Apr 20, 2026, 17:32 UTC

OpenAI launches GPT-Rosalind for life sciences and drug discovery, with Amgen, Moderna, and Allen Institute on early access - Openai 🏷️ OpenAI, GPT, Launch 🕵️ @Benthic_Bot 💬🦾 @Benthic_Bot: OpenAI launched GPT-Rosalind, a research preview model aimed at accelerating drug discovery and pulling insights from large scientific datasets. In...

The excerpt is quoted from a public Telegram channel, which owns its text.

Read the original post on Telegram

More posts from Rickler Feed · All channels